Get started
Author

H A Ghofrani

Observed names: Ghofrani, H., Ghofrani, H. A., H Ghofrani, H. A. Ghofrani, H.-A. Ghofrani, H.A. Ghofrani
OpenAlex ID: A5136405286
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
2003 · H.A. Ghofrani, F. Rose, et al. · ACC Current Journal Review · 34
Simvastatin as a Treatment for Pulmonary Hypertension Trial
2010 · M. R. Wilkins, O. Ali, et al. · American Journal of Respiratory and Critical Care Medicine · 5
Effect of sotatercept on multicomponent improvement in the PULSAR study
2022 · M Hoeper, H Ghofrani, et al. · 13.01 - Pulmonary hypertension · 1
A19-10 Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH): Results From the Phase 3 PROSERA Trial
2026 · H A Ghofrani, V V Mclaughlin, et al. · American Journal of Respiratory and Critical Care Medicine
B106-05 Efficacy and Safety of Sotatercept in Patients With Pulmonary Arterial Hypertension (PAH) Classified as Intermediate-low Risk: A Pooled Analysis From PULSAR, STELLAR, and HYPERION
2026 · M Gomberg-Maitland, H A Ghofrani, et al. · American Journal of Respiratory and Critical Care Medicine
A19-05 Efficacy and Safety of Sotatercept in Patients With Pulmonary Arterial Hypertension Receiving Double-background Therapy: A Pooled Analysis From PULSAR, STELLAR, ZENITH, and HYPERION
2026 · V V Mclaughlin, D B Badesch, et al. · American Journal of Respiratory and Critical Care Medicine
A19-03 Efficacy and Safety of Sotatercept in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Connective Tissue Disease (CTD): A Pooled Analysis From STELLAR, ZENITH, and HYPERION
2026 · R Souza, D B Badesch, et al. · American Journal of Respiratory and Critical Care Medicine
Belastungshämodynamik bei pulmonaler Hypertonie – eine prospektive Druck-Volumen-Schleifen-Studie zur rechtsventrikulären Adaptation und Prognose
2026 · B Thal, Z A Rako, et al. · Pneumologie
Seralutinib shows significant anti-fibrotic effects: evidence from patient-derived models
2026 · H A Ghofrani, R Sitapara, et al. · Pneumologie
Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension
2013 · R. Savai, S.S. Pullamsetti, et al. · European Respiratory Journal
Einfluss des Rho-Kinase-Hemmstoffs Azaindol-1 auf Hämodynamik und Gefäßremodeling bei experimenteller pulmonaler Hypertonie
2011 · D. Kosanovic, B. Dahal, et al. · Pneumologie
Pulmonary hypertonia and Morbus Osler (hereditary haemorrhagic teleangiectasia)
2006 · Reichenberger, F., Wehner, Lars-Erik, et al. · GRO
Works count: 17
Citation count: 41
H-index: 2
I10-index: 1
Year
Topic
Type